Brett Scotch, DO
Otolaryngology · Wesley Chapel, FLNPI 1770577090
Payments from drug & device makers
Across 277 payments — averaging $27.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$982
- Harmony Biosciences LLC$796
- Sanofi$694
- Inspire Medical Systems, Inc.$690
- Paratek Pharmaceuticals, Inc.$553
- Optinose US, Inc.$508
- plus $4K from 33 others
What the payments were for
- Food & beverage$7,35695%
- Education$3955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 40 | $982 |
| Harmony Biosciences LLC | 32 | $796 |
| Sanofi | 25 | $694 |
| Inspire Medical Systems, Inc. | 9 | $690 |
| Paratek Pharmaceuticals, Inc. | 1 | $553 |
| Optinose US, Inc. | 29 | $508 |
| Regeneron Healthcare Solutions, Inc. | 14 | $423 |
| Kaleo, Inc. | 24 | $385 |
| Watermark Medical, Inc. | 1 | $324 |
| Acclarent, Inc | 9 | $284 |
| Alk-abello, Inc | 15 | $261 |
| Medtronic(2 entities) | 9 | $213 |
| Avadel CNS Pharmaceuticals, LLC | 7 | $207 |
| GSK | 9 | $181 |
| Fisher & Paykel Healthcare Inc | 3 | $115 |
| Hologic Sales And Service, LLC | 1 | $104 |
| Lilly USA, LLC | 5 | $94 |
| Aerin Medical Inc. | 6 | $94 |
| Stryker | 2 | $94 |
| Philips North America LLC | 2 | $83 |
| Amgen(2 entities) | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Sanofi-aventis U.S. LLC | 1 | $62 |
| Hikma Pharmaceuticals USA | 3 | $46 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| 3b Medical, Inc. | 2 | $43 |
| Resmed Corp | 2 | $43 |
| Phadia US Inc. | 2 | $43 |
| AbbVie(2 entities) | 2 | $34 |
| AstraZeneca | 2 | $30 |
| Olympus America Inc. | 2 | $28 |
| Merck | 2 | $25 |
| Intersect ENT, Inc. | 1 | $21 |
| Hill Dermaceuticals, Inc. | 1 | $19 |
| Photonicare Inc | 1 | $18 |
| Novartis | 1 | $16 |
| CSL Behring | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Glenmark Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$553
- Inspire$437
- ARES HOME SLEEP TESTING DEVICE$324
- DUPIXENT$135
- CoolSeal Generator$104
How this compares
$7,751 in reported general payments places this provider in the 85th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 24 | $408,506 |
| Dupixent PenDupilumab | 13 | $45,892 |
| XhanceFluticasone Propionate | 40 | $38,023 |
| Epinephrine | 64 | $11,948 |
| Ipratropium Bromide | 292 | $8,066 |
| Fluticasone Propionate | 605 | $6,780 |
| Fluocinolone Acetonide Oil | 43 | $1,866 |
| Famotidine | 205 | $1,220 |
| Azelastine Hcl | 39 | $662 |
| Levocetirizine Dihydrochloride | 29 | $453 |
| Eszopiclone | 17 | $359 |
| Meclizine Hcl | 42 | $287 |
| Doxycycline Hyclate | 14 | $168 |
| Methylprednisolone | 30 | $152 |
| Mupirocin | 22 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $508 | $38,02340 claims |
| Hikma Pharmaceuticals USAEpinephrine | $46 | $11,94864 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Wesley Chapel
- Andrew AgnewWesley Chapel$14K
- Craig ShapiroHollywood$8.1M
- Adrien EshraghiMiami$2.1M
- Cecelia DamaskOrlando$771K
- Ralph TufanoSarasota$733K
- Mitchell MillerClearwater$709K
- Brian KerrGainesville$629K
- Maria SuurnaMiami$456K
- Mark TaborTampa$348K
- Franklin RimellFort Myers$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.